← SynDRA
NEBIVOLOL
SynDRA canonical compound SYN0001302 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ADRB1 |
| Mechanism of action | adrenergic receptor antagonist |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
Mechanisms of action (all sources)
- ADRB1 ANTAGONIST
- ADRB2 ANTAGONIST
- ADRB3 ANTAGONIST
- adrenergic receptor antagonist
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic beta-1 Receptor Agonists
- Adrenergic beta-Agonists
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Vasodilator Agents
ATC classes
- C07A · BETA BLOCKING AGENTS
- BETA BLOCKING AGENTS AND THIAZIDES
- BETA BLOCKING AGENTS, OTHER COMBINATIONS
- ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
Cross-references
Synonyms
- nebivolol hydrochloride
- vasoxen
- bystolic
- nebivolol HCl
- Narbivolol
- R-65824
- R65,824
- Hypoloc
- Nebilet
- Nebivolol component of byvalson
- Bystolic
- Lobivon
- Nebilong
- Nebipill
- Nebivololum
- Nubeta
- Nebivololum [Latin]
- R-67555
- Bystolic (TN)
- Nebicard-5;Nebilet (TN)
- Nebilong (TN)
- Nodon (TN)
- Nubeta (TN)
- PI-21858
- Nebicard-5 (TN)
- Nebivolol (USAN/INN)
- Nebivolol [USAN:INN:BAN]
- Alpha,alpha'-(Iminodimethylene)bis(6-fluoro-2-chromanmethanol)
- Alpha,alpha'-(Iminobis(methylene))bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
- Alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
- 1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol
- 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
- (+-)-nebivolol
- byvalson component nebivolol
- dl-Nebivolol
- nebibolol
- Hydrochloride, Nebivolol
- RefChem:56585
Reported adverse events
- Bradycardia
- Chest pain
- Dizziness
- Fatigue
- Headache
- Insomnia
- Nausea
- Rash
- Raynaud's phenomenon
Look up NEBIVOLOL in the interactive SynDRA portal →